ALLO vs MSFT: Which Stock is Better?
Side-by-side comparison of Allogene Therapeutics Inc and Microsoft Corp in 2026
ALLO
Allogene Therapeutics Inc
$2.15
MSFT
Microsoft Corp
$390.12
Key Metrics Comparison
| Metric | ALLO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $510.14M | N/A | ALLO |
| P/E Ratio | N/A | 24.50 | MSFT |
| EPS (TTM) | $N/A | $15.99 | MSFT |
| Revenue Growth | -1.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze ALLO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALLO or MSFT a better investment?
Comparing ALLO and MSFT: Allogene Therapeutics Inc has a market cap of $510.14M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALLO and MSFT?
ALLO (Allogene Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALLO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALLO or MSFT?
MSFT has higher revenue growth at 0.2% vs -1.0% for ALLO.
Which company is more profitable: ALLO or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for ALLO.
Which is the larger company: ALLO or MSFT?
Allogene Therapeutics Inc (ALLO) is larger with a market cap of $510.14M compared to N/A for MSFT.
Should I buy ALLO or MSFT in 2026?
Both ALLO and MSFT have investment merit. ALLO trades at $2.15 while MSFT trades at $390.12. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALLO and MSFT stock?
Key differences: Market Cap ($510.14M vs N/A), P/E Ratio (N/A vs 24.5x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).